Kalaris Therapeutics KLRS Ratios (2019-2026)

NASDAQ KLRS
$1.90 +0.03 (+1.60%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Kalaris Therapeutics Quarterly Ratios

Periods 29 quarters
Latest Sep 2026

Kalaris Therapeutics ratios data for the quarter ended Sep 2026. These financial ratios cover 29 quarters of results from Sep 2019 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Efficiency
Assets AverageAssets Avg.
301.56M258.84M215.54M246.85M285.39M260.56M263.37M265.50M219.55M167.47M137.57M126.76M64.35M54.63M97.97M87.01M101.46M115.77M104.67M94.27M
Equity AverageEquity Avg.
246.29M208.47M174.91M205.68M238.87M209.03M211.32M212.22M75.16M-46.28M-49.53M-70.45M-93.00M-16.37M58.49M47.49M60.34M73.69M63.11M52.54M
Invested CapitalInvested Cap.
231.86M194.03M160.38M255.14M231.68M201.80M237.60M208.31M-34.24M-45.25M-50.86M-77.08M63.87M53.12M41.87M78.81M57.13M46.90M
Leverage & Solvency
Interest Coverage RatioInterest Cover
-32.86-8.39-46.44-5.45-7.18
Debt Ratio
0.020.010.010.010.030.030.030.050.060.020.013.17-0.01-0.01
Times Interest Earned
-32.86-8.39-46.44-5.45-7.18
Valuation
Price to BookP/B
83.9852.0536.7566.3940.2843.7532.3028.850.510.942.581.631.941.681.45
Enterprise Value
18,670.36M9,775.61M5,638.79M16,547.30M8,810.71M8,263.84M7,153.24M5,422.35M1,601.39M1,853.85M1,788.05M2,026.40M-69.92M-68.42M-38.49M108.02M10.86M27.77M3.39M-14.10M
Market Capitalization
18,918.48M9,977.01M5,811.49M16,811.40M9,044.51M8,466.44M7,399.74M5,635.65M1,785.29M1,994.35M1,917.65M2,148.30M48.38M32.55M49.94M108.10M128.86M132.67M96.89M68.80M
Return Ratios
Return on Capital Employed [ROCE]ROCE
-64.40%-75.83%-97.51%-82.50%-65.58%-72.68%-74.71%-76.55%-104.56%-99.64%-85.88%-85.37%-130.49%-125.35%-74.84%-52.49%-50.31%-44.23%-49.79%-54.61%
Return on Invested Capital [ROIC]ROIC
-89.80%-70.22%-79.04%-79.59%-228.97%
Return on Assets [ROA]ROA
-57.04%-71.57%-89.25%-76.54%-59.23%-63.70%-63.20%-63.46%-86.54%-107.11%-101.96%-105.79%-150.07%-139.83%-83.35%-63.74%-42.81%-38.13%-42.36%-46.11%
Return on Equity [ROE]ROE
-69.84%-88.87%-109.99%-91.86%-70.76%-79.41%-78.76%-79.40%-252.82%-139.60%-116.78%-71.98%-59.91%-70.25%-82.74%

Kalaris Therapeutics Ratios API

Pull Kalaris Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=KLRS&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY